HOME >> MEDICINE >> NEWS
Paclitaxel combination improves survival from small-cell lung cancer

Combining paclitaxel (Taxol) with two other chemotherapy drugs appears to improve survival in patients with small-cell lung cancer (SCLC) compared with a standard regimen without paclitaxel, according to results from a randomized clinical trial in the August 6 issue of the Journal of the National Cancer Institute.

The study found that treatment with paclitaxel, etoposide, and carboplatin yielded better rates of survival and fewer side effects than treatment with carboplatin, etoposide, and vincristine--one standard chemotherapy regimen. Paclitaxel, both alone and in combination with other chemotherapy drugs, has been associated with high response rates in smaller studies of patients with SCLC, the most aggressive form of lung cancer.

Martin Reck, M.D., and Ulrich Gatzemeier, M.D., of the Hospital Grosshansdorf in Hamburg, Germany, and their colleagues conducted a randomized, phase III trial of the two regimens in 614 patients with SCLC. Patients were evaluated for response rate, survival, and toxicities.

Tumor response rates of the two groups were similar. However, patients who received the experimental treatment had a longer median survival time (12.7 months versus 11.7 months) than patients who received standard chemotherapy. The 3-year survival rate of patients in the experimental group was nearly twice that of patients in the standard treatment group (17% versus 9%, respectively). Notably, the improvements in survival were limited to patients with early-stage disease.

Patients in the experimental group also experienced a longer median progression-free survival time (8.1 months versus 7.5 months) than patients in the standard treatment group. For each completed chemotherapy cycle, rates of side effects, such as severe anemia and thrombocytopenia, were lower for patients in the experimental group than patients in the standard treatment group.

"Our results are the first from a randomized trial to demonstrate a st
'"/>

Contact: Linda Wang
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
5-Aug-2003


Page: 1 2

Related medicine news :

1. Paclitaxel chemotherapy for breast cancer not associated with serious radiation pneumonitis
2. Three anti-platelet drugs used in combination are safe
3. No advantage of combination drug therapy for chronic hepatitis B Infection
4. Certain high blood pressure combination therapies elevate risk for death from cardiovascular disease
5. Ugandan study highlights best drug combinations for treating malaria in Africa
6. Drug combination shows promise in treating hepatitis C
7. Study shows weight-based REBETOL dosing in combination with PEG-INTRON significantly improves ...
8. Therapy, medication combination superior for children with obsessive-compulsive disorder
9. Yerkes researchers discover combination of drug therapies reduces cocaine use in primates
10. Diabetes drug improves metabolic changes associated with HIV combination therapy
11. Study finds combination therapy successful for treating depression

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/28/2020)... ... May 28, 2020 , ... ... new 7th Donor Shield protection. Donors can now be reimbursed for lost wages ... program. The other six Donor Shield protections include lost wage reimbursement for donation, ...
(Date:5/27/2020)... ... May 27, 2020 , ... ... of Washington Professor of Bioengineering, Founder & Editor of scientific journal WATER, ... ( https://www.amazon.com/Fourth-Phase-Water-Beyond-Liquid-ebook/dp/B00N2ASKF2 ) , https://www.voiceamerica.com/episode/123059/the-fourth-phase-of-water , * , During ...
(Date:5/26/2020)... ... May 26, 2020 , ... As much ... across the United States are joining forces to start a country-wide movement of ... tirelessly to save lives. #FitForTheFrontLine is a national fitness challenge beginning Tuesday, May ...
(Date:5/21/2020)... ... May 21, 2020 , ... Fujirebio Diagnostics, Inc., ... biomarker assays, announced today that Cigna has added ROMA® (Risk of Ovarian Malignancy ... service company dedicated to improving the health, well-being, and peace of mind of ...
(Date:5/21/2020)... ... ... ESO , the leading data and software company serving emergency medical services ... Fire Service Index . The Index looks at key trends across fire departments nationwide, ... travel time, the most common property types visited and estimated property loss, as well ...
Breaking Medicine News(10 mins):
(Date:5/27/2020)... (PRWEB) , ... May 27, 2020 , ... Focus ... and cloud solutions, has announced it will once again sponsor the American Heart Association’s ... Good Champion. This will mark the third year the firm is sponsoring the AHA ...
(Date:5/26/2020)... ... May 26, 2020 , ... Melwood is proud to be donating thousands ... hospitals, food pantries, group homes and nursing homes. “It’s more important than ever to ... front lines and bring a little cheer to seniors and individuals of differing abilities,” ...
(Date:5/25/2020)... ... May 24, 2020 , ... May is ... electricians, want the public to know what safety resources are available. Every year ... (ESFI) launches an education campaign to inform the public about safety steps that ...
Breaking Medicine Technology:
Cached News: